Hypertension:- Def, Causes, Pathology, Clinical fectures, Investigation & Management
Reading File
Finding Sources
Searching PubMed
"hypertension"[MeSH Terms] AND "management"[MeSH Terms]
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Now I have enough comprehensive information to compose a thorough, well-structured answer. Let me compile all the data gathered.
Hypertension - Comprehensive Overview
1. Definition
Hypertension is defined as a sustained elevation in blood pressure (BP) at or above 130/80 mm Hg (ACC/AHA 2017 guideline) or ≥140/90 mm Hg by the traditional WHO/JNC definition, confirmed on two or more separate occasions.
Classification (JNC/ACC-AHA framework):
| Category | Systolic (mmHg) | Diastolic (mmHg) |
|---|---|---|
| Normal | < 120 | < 80 |
| Elevated | 120-129 | < 80 |
| Stage 1 Hypertension | 130-139 | 80-89 |
| Stage 2 Hypertension | ≥ 140 | ≥ 90 |
| Hypertensive Crisis | > 180 | > 120 |
Using the ACC/AHA 2017 criteria, the prevalence of hypertension among US adults is approximately 45%. - Symptom to Diagnosis, 4th Edition
2. Causes
A. Primary (Essential) Hypertension (~90-95% of cases)
Primary (essential) hypertension accounts for >90% of all cases and has no single identifiable cause. However, several contributing factors are well-established:
- Overweight/Obesity: Accounts for 65-75% of the risk for primary hypertension. Visceral adiposity activates the renin-angiotensin-aldosterone system (RAAS), increases renal sodium reabsorption, and stimulates the sympathetic nervous system (SNS).
- Sedentary lifestyle and high sodium chloride intake
- Excess alcohol consumption
- Low potassium intake
- Genetic factors: Family history strongly predicts essential hypertension. Rare monogenic causes include Liddle syndrome, Gordon syndrome, familial hyperaldosteronism (FH-I/GRA), and apparent mineralocorticoid excess (AME).
B. Secondary Hypertension (~5-10% of cases)
| Category | Causes |
|---|---|
| Endocrine | Primary hyperaldosteronism (most common, 5-10% unselected; 20% in resistant HTN), Pheochromocytoma (0.04-0.2%), Cushing syndrome (0.3%), Thyroid disease, Hyperparathyroidism |
| Renal | Chronic kidney disease, Acute kidney injury |
| Vascular | Renovascular disease/renal artery stenosis (0.18-4.4%), Coarctation of the aorta |
| Respiratory | Obstructive sleep apnea |
| Drug-induced | NSAIDs, COX-2 inhibitors, oral contraceptives, corticosteroids, cocaine, sympathomimetics, cyclosporine/tacrolimus, erythropoietin, stimulants (amphetamines) |
| Other | Obesity (GI/metabolic), ureteral/bladder outlet obstruction |
- Symptom to Diagnosis, 4th Edition; Fuster and Hurst's The Heart, 15th Edition
3. Pathology / Pathophysiology
A. RAAS Activation
Excess sodium retention, renal artery ischemia, or angiotensin II excess drives sustained vasoconstriction and sodium/water retention, increasing preload and vascular resistance.
B. Sympathetic Nervous System (SNS) Overactivity
Obesity - especially visceral fat - increases leptin and stimulates the SNS. Chronic SNS activation raises heart rate, cardiac output, and peripheral vascular resistance. In obese patients, the kidneys are compressed by perinephric/intrarenal fat, impairing pressure natriuresis.
C. Obesity and Kidney Compression
Perinephric fat directly compresses renal tubules, elevating intrarenal pressure and shifting the pressure-natriuresis curve - the kidney requires higher arterial pressure to excrete a normal sodium load.
D. Vascular Remodeling
Sustained high BP causes structural changes:
- Arteriolosclerosis - hyaline and hyperplastic thickening of arteriolar walls
- Left ventricular hypertrophy (LVH) - concentric hypertrophy due to increased afterload
- Endothelial dysfunction - impaired nitric oxide-dependent vasodilation
E. Insulin Resistance / Metabolic Syndrome
Hypertension, dyslipidemia, hyperglycemia, and obesity cluster together. While insulin resistance does not directly cause hypertension (hyperinsulinemia per se does not raise BP in humans), the associated vascular and renal injury from metabolic syndrome contributes to BP elevation over time.
F. Target Organ Damage (Pathological Consequences)
| Organ | Lesion |
|---|---|
| Heart | LVH, diastolic dysfunction, coronary artery disease, heart failure |
| Brain | Lacunar infarcts, hypertensive encephalopathy, hemorrhagic stroke |
| Kidneys | Hypertensive nephrosclerosis, CKD, proteinuria |
| Eyes | Hypertensive retinopathy (arteriovenous nicking, cotton-wool spots, papilledema in severe cases) |
| Arteries | Aortic dissection, accelerated atherosclerosis, peripheral artery disease |
- Fuster and Hurst's The Heart, 15th Edition; Brenner and Rector's The Kidney
4. Clinical Features
Hypertension is classically called the "silent killer" because most patients are asymptomatic until complications arise.
Symptoms (when present):
- Headache (classically occipital, worse in the morning - seen in severe/malignant hypertension)
- Dizziness and palpitations
- Epistaxis
- Blurred vision
- In hypertensive emergencies: chest pain, dyspnea, neurological deficits, acute visual loss
Physical Examination Findings:
| System | Finding |
|---|---|
| Cardiovascular | Loud A2, S4 gallop (indicates LVH/reduced compliance), laterally displaced apex |
| Fundoscopy | Arteriovenous nicking, arteriolar narrowing, flame hemorrhages, cotton-wool spots, papilledema (grade IV) |
| Neurological | Signs of stroke if cerebrovascular involvement |
| Peripheral | Reduced pulses if PAD; absent femoral pulses (coarctation) |
| Abdominal | Renal artery bruit (renovascular HTN) |
Hypertensive Retinopathy - Keith-Wagener-Barker Classification:
- Grade I: Increased light reflex, arteriovenous (AV) ratio narrowing
- Grade II: AV nicking (copper/silver wiring)
- Grade III: Flame hemorrhages, cotton-wool spots
- Grade IV: Papilledema - indicates malignant hypertension
A clinical case example: BP of 165/90 mmHg with arteriolar narrowing on fundoscopy and an S4 on cardiac exam - typical of sustained essential hypertension with early target organ involvement. - Symptom to Diagnosis, 4th Edition
5. Investigations
Baseline (All Hypertensive Patients):
- BP measurement in both arms, two or more readings on two or more occasions; average of readings used
- Fasting blood glucose / HbA1c
- Serum electrolytes (sodium, potassium - hypokalemia suggests hyperaldosteronism)
- Serum creatinine + eGFR (renal function)
- Lipid profile (total cholesterol, LDL, HDL, triglycerides)
- Serum calcium (hyperparathyroidism)
- TSH (thyroid disease)
- Complete blood count
- Urinalysis (proteinuria, casts)
- Urinary albumin-to-creatinine ratio (microalbuminuria = early renal damage)
- 12-lead ECG (LVH, strain pattern, arrhythmias)
Additional Investigations (Targeted):
- Echocardiogram - LVH assessment, diastolic dysfunction, wall motion
- Renal ultrasound - kidney size, obstruction, polycystic kidneys
- 24-hour ambulatory BP monitoring (ABPM) - white-coat HTN, masked HTN, circadian patterns
- Uric acid - gout risk if thiazides planned
For Secondary Hypertension (if suspected):
| Suspected Cause | Investigation |
|---|---|
| Primary Hyperaldosteronism | Aldosterone-renin ratio (ARR), adrenal CT, adrenal vein sampling |
| Pheochromocytoma | 24-hr urine catecholamines/metanephrines, plasma metanephrines, CT abdomen |
| Renovascular HTN | Renal Doppler ultrasound, MR angiography, captopril renal scan |
| Cushing Syndrome | 24-hr urinary free cortisol, overnight dexamethasone suppression test |
| Sleep Apnea | Polysomnography |
| CKD | Creatinine, eGFR, renal biopsy if needed |
| Coarctation of Aorta | CT angiography, echocardiogram |
| Thyroid disease | TSH, free T4 |
- Fuster and Hurst's The Heart, 15th Edition
6. Management
A. Lifestyle Modifications (For All Patients)
These are first-line for all stages of hypertension:
| Modification | Expected SBP Reduction |
|---|---|
| Weight loss (per kg) | ~1 mmHg |
| DASH diet (rich in fruits, vegetables, low-fat dairy) | 8-14 mmHg |
| Dietary sodium restriction (<1.5-2.4 g/day) | 2-8 mmHg |
| Regular aerobic exercise (30 min/day, most days) | 4-9 mmHg |
| Alcohol moderation (≤2 drinks/day men, ≤1 women) | 2-4 mmHg |
| Smoking cessation (reduces overall CVD risk) | Indirect |
B. Pharmacological Treatment
When to start medications:
- Stage 1 HTN (130-139/80-89) with high CVD risk (10-year ASCVD ≥10%, diabetes, CKD, prior CVD)
- Stage 2 HTN (≥140/90) - medications indicated for all
- SPRINT trial supports targeting SBP <120 mmHg in high-risk patients
First-line drug classes:
| Drug Class | Examples | Indication/Notes |
|---|---|---|
| Thiazide diuretics | Chlorthalidone, HCTZ, Indapamide | Preferred first-line, especially in Black patients; check K+ |
| ACE Inhibitors (ACEi) | Lisinopril, Ramipril, Enalapril | Preferred in diabetes, CKD with proteinuria, heart failure; avoid in pregnancy |
| Angiotensin Receptor Blockers (ARBs) | Losartan, Valsartan, Irbesartan | Used if ACEi-intolerant (cough); preferred in CKD with proteinuria |
| Calcium Channel Blockers (CCBs) | Amlodipine (DHP), Diltiazem/Verapamil (non-DHP) | Preferred in elderly, isolated systolic HTN, angina; non-DHPs slow HR |
| Beta-Blockers | Metoprolol, Atenolol, Carvedilol | Preferred in heart failure, post-MI, angina, tachyarrhythmias |
Compelling indications guide drug choice:
- Diabetes + HTN: ACEi or ARB (renoprotective)
- Heart failure: ACEi/ARB + beta-blocker + loop diuretic
- CKD with proteinuria: ACEi or ARB
- Post-MI: Beta-blocker + ACEi
- Isolated systolic HTN in elderly: Thiazide or dihydropyridine CCB
- Primary hyperaldosteronism: Spironolactone/Eplerenone
BP Treatment Targets:
- General population: < 130/80 mmHg (ACC/AHA) or <140/90 mmHg (ESC/ESH)
- CKD with proteinuria: < 130/80 mmHg
- Elderly (>65): < 130 mmHg SBP if tolerated (SPRINT data)
- Pregnancy: 130-150/80-100 mmHg (avoid ACEi/ARBs)
C. Resistant Hypertension
Defined as BP uncontrolled despite ≥3 antihypertensive drugs at optimal doses (including a diuretic). Consider:
- Checking adherence and white-coat effect
- Adding spironolactone (most effective 4th-line agent)
- Investigating for secondary causes (primary hyperaldosteronism most common at ~20%)
- Renal denervation (in selected patients)
D. Hypertensive Emergency vs. Urgency
-
Emergency: BP >180/120 with end-organ damage (encephalopathy, acute MI, aortic dissection, acute heart failure, retinal hemorrhages) - IV labetalol, nicardipine, nitroprusside; reduce SBP by ≤25% in first hour
-
Urgency: BP >180/120 without end-organ damage - oral agents, gradual reduction over 24-48 hours
-
Fuster and Hurst's The Heart, 15th Edition; Symptom to Diagnosis, 4th Edition
Summary: Hypertension is the most prevalent modifiable cardiovascular risk factor globally, affecting roughly half of adults. The vast majority is primary/essential with obesity being the dominant modifiable cause. Management requires accurate BP measurement, CVD risk stratification, targeted investigation to exclude secondary causes, and a combination of lifestyle modification with pharmacotherapy guided by comorbidities and compelling indications.
This is a shared conversation. Sign in to Orris to start your own chat.